Overly cautious : No evidence AstraZeneca s COVID-19 vaccine linked to blood clots
A handful of European nations pause rollout of the Oxford-AstraZeneca vaccine while authorities investigate possible clotting issues. Listen - 03:18
A host of European countries have paused the rollout of the AstraZeneca vaccine to investigate blood clots in those who had been vaccinated. Getty/Jens Schleuter
Though there is no evidence that the COVID-19 vaccine developed by Oxford University and AstraZeneca increases the risk of blood clots, a handful of European nations announced Monday they will pause their rollout while the European Medicines Agency (EMA) investigates.
The pause in France, Germany, Italy and Spain comes less than a week after Austria and other EU nations stopped administering AstraZeneca vaccinations from a particular batch of 1 million doses.